Ligustrazine improves the compensative effect of Akt survival signaling to protect liver Kupffer cells in trauma-hemorrhagic shock rats
© 2023 John Wiley & Sons Ltd..
Trauma-hemorrhagic shock (THS) is a medical emergency that is encountered by physicians in the emergency department. Chuan Xiong is a traditional Chinese medicine and ligustrazine is a natural compound from it. Ligustrazine improves coronary blood flow and reduces cardiac ischemia in animals through Ca2+ and ATP-dependent vascular relaxation. It also decreases the platelets' bioactivity and reduces reactive oxygen species formation. We hypothesized that ligustrazine could protect liver by decreasing the inflammation response, protein production, and apoptosis in THS rats. Ligustrazine at doses of 100 and 1000 μg/mL was administrated in Kupffer cells isolated from THS rats. The protein expressions were detected via western blot. The THS showed increased inflammation response proteins, mitochondria-dependent apoptosis proteins, and had a compensation effect on the Akt pathway. After ligustrazine treatment, the hemorrhagic shock Kupffer cells decreased inflammatory response and mitochondria-dependent apoptosis and promoted a more compensative effect of the Akt pathway. It suggests ligustrazine reduces inflammation response and mitochondria-dependent apoptosis induced by THS in liver Kupffer cells and promotes more survival effects by elevating the Akt pathway. These findings demonstrate the beneficial effects of ligustrazine against THS-induced hepatic injury, and ligustrazine could be a potential medication to treat the liver injury caused by THS.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:102 |
---|---|
Enthalten in: |
Chemical biology & drug design - 102(2023), 6 vom: 23. Dez., Seite 1399-1408 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chen, Ray-Jade [VerfasserIn] |
---|
Links: |
---|
Themen: |
EC 2.7.11.1 |
---|
Anmerkungen: |
Date Completed 09.11.2023 Date Revised 29.11.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/cbdd.14327 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM361105495 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM361105495 | ||
003 | DE-627 | ||
005 | 20231226084436.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/cbdd.14327 |2 doi | |
028 | 5 | 2 | |a pubmed24n1203.xml |
035 | |a (DE-627)NLM361105495 | ||
035 | |a (NLM)37612133 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chen, Ray-Jade |e verfasserin |4 aut | |
245 | 1 | 0 | |a Ligustrazine improves the compensative effect of Akt survival signaling to protect liver Kupffer cells in trauma-hemorrhagic shock rats |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 09.11.2023 | ||
500 | |a Date Revised 29.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 John Wiley & Sons Ltd. | ||
520 | |a Trauma-hemorrhagic shock (THS) is a medical emergency that is encountered by physicians in the emergency department. Chuan Xiong is a traditional Chinese medicine and ligustrazine is a natural compound from it. Ligustrazine improves coronary blood flow and reduces cardiac ischemia in animals through Ca2+ and ATP-dependent vascular relaxation. It also decreases the platelets' bioactivity and reduces reactive oxygen species formation. We hypothesized that ligustrazine could protect liver by decreasing the inflammation response, protein production, and apoptosis in THS rats. Ligustrazine at doses of 100 and 1000 μg/mL was administrated in Kupffer cells isolated from THS rats. The protein expressions were detected via western blot. The THS showed increased inflammation response proteins, mitochondria-dependent apoptosis proteins, and had a compensation effect on the Akt pathway. After ligustrazine treatment, the hemorrhagic shock Kupffer cells decreased inflammatory response and mitochondria-dependent apoptosis and promoted a more compensative effect of the Akt pathway. It suggests ligustrazine reduces inflammation response and mitochondria-dependent apoptosis induced by THS in liver Kupffer cells and promotes more survival effects by elevating the Akt pathway. These findings demonstrate the beneficial effects of ligustrazine against THS-induced hepatic injury, and ligustrazine could be a potential medication to treat the liver injury caused by THS | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Kupffer cells | |
650 | 4 | |a ligustrazine | |
650 | 4 | |a liver | |
650 | 4 | |a tetramethylpyrazine | |
650 | 4 | |a trauma-hemorrhagic shock | |
650 | 7 | |a Proto-Oncogene Proteins c-akt |2 NLM | |
650 | 7 | |a EC 2.7.11.1 |2 NLM | |
650 | 7 | |a tetramethylpyrazine |2 NLM | |
650 | 7 | |a V80F4IA5XG |2 NLM | |
700 | 1 | |a Chen, Ming-Cheng |e verfasserin |4 aut | |
700 | 1 | |a Tsai, Bruce Chi-Kang |e verfasserin |4 aut | |
700 | 1 | |a Roy, Rakesh |e verfasserin |4 aut | |
700 | 1 | |a Chang, Yi-Ru |e verfasserin |4 aut | |
700 | 1 | |a Wang, Tso-Fu |e verfasserin |4 aut | |
700 | 1 | |a Kuo, Wei-Wen |e verfasserin |4 aut | |
700 | 1 | |a Kuo, Chia-Hua |e verfasserin |4 aut | |
700 | 1 | |a Yao, Chun-Hsu |e verfasserin |4 aut | |
700 | 1 | |a Li, Chi-Cheng |e verfasserin |4 aut | |
700 | 1 | |a Huang, Chih-Yang |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Chemical biology & drug design |d 2006 |g 102(2023), 6 vom: 23. Dez., Seite 1399-1408 |w (DE-627)NLM160848377 |x 1747-0285 |7 nnns |
773 | 1 | 8 | |g volume:102 |g year:2023 |g number:6 |g day:23 |g month:12 |g pages:1399-1408 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/cbdd.14327 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 102 |j 2023 |e 6 |b 23 |c 12 |h 1399-1408 |